JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for GENETIX BIOTHERAPEUTICS · biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $15,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

issues related to FDA regulation of rare disease therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem